StonvexLoading…
StonvexStonvexStonvexCore line items from IVT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-03-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|---|
Revenue | $81.19M | $471.00K | $1.25M | $803.00K | $382.00K |
Operating Income | Not available | $-9.77M | $68.50M | $75.79M | $-7.71M |
Net Income | Not available | $5.18M | $108.76M | $95.94M | $6.79M |
EPS (Diluted) | $0.01 | $0.07 | $1.39 | $1.31 | $0.09 |
Total Assets | Not available | $2.89B | $2.73B | $2.71B | $2.61B |
Total Liabilities | Not available | $1.11B | $925.59M | $887.20M | $860.70M |
Cash & Equivalents | Not available | $34.40M | $76.37M | $294.04M | $84.58M |
Free Cash Flow OCF − CapEx | Not available | $14.11M | $82.17M | $50.76M | $12.81M |
Shares Outstanding | Not available | 77.94M | 77.62M | 77.61M | 77.57M |